Fujifilm Medical Systems USA

Fujifilm Medical Systems USA (Booth 4039) is showcasing a full line-up of breast imaging solutions highlighted by a new detector technology featuring Direct Optical Switching (DOS). Complementing Fujifilm’s current digital mammography products, it will be the first amorphous selenium detector with a 50-micron pixel size.  Plans for commercialization will be announced.  

Also being featured at RSNA is the recently launched Breast Imaging Diagnostic Workstation which delivers Synapse PACS multi-modality breast imaging functionality to complement the company’s full-field digital mammography (FFDM) offering; it can be installed as an image and information management solution or it can be a supplement to facilities’ existing PACS. Fuji also is displaying a working model of a mammography suite including the latest in CR-based FFDM technology.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.